NLS Pharmaceuticals to Reschedule Company Update on Strategic Discussions
NLS Pharmaceutics postpones company update due to important developments
10/19/2023 - 05:00 PM
ZURICH, SWITZERLAND / ACCESSWIRE / October 19, 2023 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced that it will postpone the company update previously scheduled for Friday, October 20, 2023, due to important developments impacting the timing of the event.
About NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd. (Nasdaq:NLSP) is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders who have unmet medical needs. Headquartered in Switzerland and founded in 2015, NLS is led by an experienced management team with a track record of developing and commercializing product candidates. For more information, please visit www.nlspharma.com .
For additional information:
Marianne Lambertson (investors & media) ml@nls-pharma.com www.nlspharmaceutics.com
SOURCE: NLS Pharmaceutics AG
https://www.accesswire.com/794639/nls-pharmaceuticals-to-reschedule-company-update-on-strategic-discussions
Why did NLS Pharmaceutics postpone the company update?
Due to important developments impacting the timing of the event.
What is NLS Pharmaceutics?
NLS Pharmaceutics is a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders.
What is the stock ticker symbol for NLS Pharmaceutics?
The stock ticker symbol for NLS Pharmaceutics is NLSP.
What is the stock ticker symbol for NLS Pharmaceutics warrants?
The stock ticker symbol for NLS Pharmaceutics warrants is NLSPW.
When was the company update originally scheduled?
The company update was originally scheduled for Friday, October 20, 2023.
NLSP Rankings
#633 Ranked by Stock Gains
NLSP Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major
About NLSP
mission & values to serve our patients we design affordable, safe and effective therapeutics to safeguard and empower the brain throughout all stages of life. we value partnership and integrity, we are ethical and responsible and show respect and compassion for our patients. r&d strategy the successful companies of tomorrow are those that go beyond delivering products to delivering real solutions and services. r&d is the cornerstone of our company and we promote ingenuity through an effective intellectual property policy. the advancements in science mean that more targeted, more (cost-)effective treatments are within reach and we are here to take on this challenge. our innovative r&d is centered on patients’ needs and delivering affordable, safe and effective solutions. not only will these enable us to improve access to quality healthcare and meet unmet needs, but they will also deliver the sustainable growth required to allow us to continue to invest in innovative research & developm
